Phreesia Inc

13 nov 2026, 21:07 UTC

Phreesia, Inc. is experiencing a modest price increase, supported by significant gains in the Health Care Technology sub-sector, and is near the upper end of its one-month range.

12 nov 2026, 21:07 UTC

Bronstein, Gewirtz & Grossman, LLC is investigating Phreesia, Inc. for potential corporate wrongdoing by the company and its officers or directors.

11 nov 2026, 21:06 UTC

JPMorgan downgraded Phreesia, Inc. from Neutral to Underweight, citing concerns over strategic clarity and setting a price target of $13.00.

9 nov 2026, 20:46 UTC

Phreesia, Inc. shares are trading higher, reaching a notable peak around midday and remaining above its 20-day moving average since Friday's close.

6 nov 2026, 21:06 UTC

Phreesia, Inc. shares are declining, pulling back from earlier gains, and have faced a modest decline since Thursday's close.

5 nov 2026, 21:08 UTC

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing at Phreesia, Inc., raising governance concerns among investors.

4 nov 2026, 21:03 UTC

Phreesia, Inc. gains recognition as Vice President Sophia Wagner is named to Becker’s 2026 list of Health IT & Revenue Cycle Up-and-Comers.

2 nov 2026, 21:09 UTC

Phreesia, Inc. is trading modestly higher, benefiting from its acquisition of AccessOne and its ongoing transition to operating profitability.

23 oct 2026, 20:07 UTC

Phreesia Inc shares are declining amid a broader market downturn influenced by key economic indicators and concerns over rising oil prices.

22 oct 2026, 20:07 UTC

Phreesia Inc shares are advancing, reflecting the broader market's upward trend, marking five consecutive sessions of gains and trading significantly above its 20-day moving average.

21 oct 2026, 20:03 UTC

Phreesia Inc shares are advancing, continuing a trend of higher finishes, despite an earlier pullback from a session high amid broader market gains.

20 oct 2026, 20:01 UTC

Phreesia Inc shares are sharply higher, marking a divergence from the recent trend of higher daily closes observed since Monday's close.

16 oct 2026, 19:46 UTC

Phreesia Inc shares fell modestly after retracing from an earlier high.

15 oct 2026, 20:51 UTC

Phreesia Inc shares advanced in after-market trading, recovering from an initial slight loss to achieve a notable gain above the 20-day moving average.

12 oct 2026, 20:06 UTC

Barclays maintains Equal-Weight rating on Phreesia Inc and raises price target to $11, citing recent performance and market conditions.

8 oct 2026, 19:24 UTC

Michael Rasbury of Phreesia has been named to Becker’s Hospital Review’s 2026 list of Rising Stars in Healthcare, recognizing his contributions to patient financial engagement.

7 oct 2026, 20:07 UTC

Phreesia Inc is experiencing a higher trading session, continuing its upward trajectory since Tuesday, supported by strong performance in the health care technology sector.

29 sept 2026, 20:07 UTC

Phreesia, Inc. shares fell sharply as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing involving the company and its directors.

24 sept 2026, 20:07 UTC

Phreesia Inc. shares are advancing during Thursday's session, following an early spike that marked the stock's highest point shortly after the market opened.

23 sept 2026, 20:07 UTC

Phreesia Inc's stock is declining, reflecting investor concerns following the sale of 6.66k shares by General Counsel Hoffman Allison C on September 21, 2026.

8 sept 2026, 20:02 UTC

Phreesia Inc shares are lower after Raymond James downgraded the stock to Market Perform. An investigation by Bronstein, Gewirtz & Grossman, LLC adds to investor concerns.

4 sept 2026, 20:08 UTC

Phreesia Inc shares are lower as DA Davidson cuts its price target to $13.00 despite the company reporting a profitable quarter with $1.9 million net income.

3 sept 2026, 20:02 UTC

Phreesia Inc shares are lower after mixed Q2 results and an investigation announcement. RBC Capital maintained its "Outperform" rating and $19 price target.

2 sept 2026, 23:36 UTC

Phreesia shares declined after reporting second-quarter revenues of $129.5 million, while earnings per share of $0.03 missed expectations of $0.09.

28 ago 2026, 20:08 UTC

Phreesia Inc's shares are higher today, continuing a trend of gains over the past three sessions. No specific news was identified for the movement.

25 ago 2026, 19:16 UTC

Phreesia Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares during the session.

24 ago 2026, 19:46 UTC

Phreesia Inc shares are lower today amid broader market pressures from rising oil prices and geopolitical tensions, including new U.S. sanctions against Iran.

21 ago 2026, 19:36 UTC

Phreesia Inc is higher today, rebounding from an earlier dip. The stock reflects positive sentiment in health care technology amid rising yields.

20 ago 2026, 19:46 UTC

Phreesia Inc is trading higher as initial jobless claims fall below expectations, indicating strength in the labor market and supporting broader economic conditions.

19 ago 2026, 20:02 UTC

Phreesia Inc. shares are rising today, supported by gains in the ARK Genomic Revolution ETF and broader health care technology stocks.